Orbis Investment Management (US)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-68,273
Closed -$3.75M 25
2016
Q2
$3.75M Sell
68,273
-102,598
-60% -$5.46M 3.15% 14
2016
Q1
$8.63M Buy
170,871
+10,193
+6% +$499K 7.45% 4
2015
Q4
$8.1M Hold
160,678
6.96% 4
2015
Q3
$7.57M Buy
160,678
+6,684
+4% +$355K 6.86% 3
2015
Q2
$8.37M Buy
153,994
+37,807
+33% +$2.12M 6.75% 4
2015
Q1
$6.37M Buy
116,187
+13,255
+13% +$751K 5.24% 8
2014
Q4
$5.58M Buy
+102,932
New +$5.73M 4.62% 9

Other funds holding MRK

Orbis Investment Management (US)'s MRK Position: Q3 2016 in Review

Orbis Investment Management (US) sold out of Merck (MRK) in Q3 2016, closing a stake of 68,273 shares — an estimated $3.75M sold.

Orbis Investment Management (US) first reported a position in MRK in Q4 2014 and held it in 7 quarters. The position peaked at $8.63M in Q1 2016. 1,814 funds tracked by Wall St. Rank hold MRK as of Q3 2016.

  • Orbis Investment Management (US) reported no remaining Merck position as of Q3 2016 after selling out during the quarter.
  • Orbis Investment Management (US) sold 68,273 Merck shares in Q3 2016, an estimated $3.75M.
  • Orbis Investment Management (US) first reported a position in Merck in Q4 2014 and held it in 7 quarters.
  • Orbis Investment Management (US)'s Merck position peaked at $8.63M in Q1 2016.
  • 1,814 funds tracked by Wall St. Rank held Merck as of Q3 2016.

Based on Orbis Investment Management (US)'s 13F filing for Q3 2016, filed 14 Nov 2016.